Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.
Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Genovese AV, et al. Among authors: lizarraga aa. Radiology. 2019 Nov;293(2):424-433. doi: 10.1148/radiol.2019190306. Epub 2019 Sep 24. Radiology. 2019. PMID: 31549947 Free PMC article.
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study.
Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B. Zivadinov R, et al. Among authors: lizarraga aa. J Clin Med. 2019 Mar 12;8(3):344. doi: 10.3390/jcm8030344. J Clin Med. 2019. PMID: 30870983 Free PMC article.
Multiple sclerosis in 2019: predicting progression.
Lizarraga AA, Weinstock-Guttman B. Lizarraga AA, et al. Lancet Neurol. 2020 Jan;19(1):12-14. doi: 10.1016/S1474-4422(19)30441-7. Lancet Neurol. 2020. PMID: 31839238 No abstract available.
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis.
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. Ghione E, et al. Among authors: lizarraga aa. AJNR Am J Neuroradiol. 2020 Sep;41(9):1577-1583. doi: 10.3174/ajnr.A6684. Epub 2020 Aug 6. AJNR Am J Neuroradiol. 2020. PMID: 32763899 Free PMC article.
Late onset multiple sclerosis is associated with more severe ventricle expansion.
Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R. Jakimovski D, et al. Mult Scler Relat Disord. 2020 Nov;46:102588. doi: 10.1016/j.msard.2020.102588. Epub 2020 Oct 17. Mult Scler Relat Disord. 2020. PMID: 33296984
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. Hildesheim FE, et al. Among authors: lizarraga aa. Mult Scler Relat Disord. 2021 Jan;47:102653. doi: 10.1016/j.msard.2020.102653. Epub 2020 Dec 4. Mult Scler Relat Disord. 2021. PMID: 33333417
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.
Jakimovski D, Zakalik K, Awan S, Kavak KS, Pennington P, Hojnacki D, Kolb C, Lizarraga AA, Eckert SP, Sarrosa R, Vineetha K, Edwards K, Weinstock-Guttman B. Jakimovski D, et al. Among authors: lizarraga aa. Vaccines (Basel). 2022 Apr 28;10(5):695. doi: 10.3390/vaccines10050695. Vaccines (Basel). 2022. PMID: 35632451 Free PMC article.
21 results